IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,035.00
Bid: 4,059.00
Ask: 4,062.00
Change: -55.00 (-1.34%)
Spread: 3.00 (0.074%)
Open: 4,098.00
High: 4,120.00
Low: 4,035.00
Prev. Close: 4,090.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

6 Feb 2012 14:00

RNS Number : 8693W
Croda International PLC
06 February 2012
 



6 February 2012

 

Croda International Plc

 

Appointment of Chief Technology Officer

Croda International Plc, the speciality chemicals company, is pleased to announce that Keith Layden has been appointed to the Board as an executive director with immediate effect, in the new role of Chief Technology Officer.

Keith joined Croda in 1984 and for the past 7 years has been President of our Enterprise Technology and Actives businesses, where he has overseen significant growth in innovation and expansion into new product areas. Prior to this he held a number of Managing Director roles across our European business. As Chief Technology Officer, Keith will be responsible for accelerating the identification, development, licensing and acquisition of innovative technologies, the global co-ordination of Croda's R&D activities and the development of novel production processes for our major existing core product platforms.

Steve Foots, Croda's Chief Executive, commented,

"Keith's appointment to the Board is recognition of the importance the capture of external technologies is to our short and medium term growth plans. This is an exciting new role for Keith and the organisation."

Martin Flower, Croda's Chairman, commented,

 "We are delighted that Keith has joined the Croda Board in this important new role. His wealth of experience of the chemical industry and its related technologies will be of great value during the next phase of Croda's development. "

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

Enquiries:

Ben Foster, Pendomer Communications

020 3603 5221

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABXGDDCBGBGDL
Date   Source Headline
20th Apr 20187:00 amRNSDirectorate Change
19th Apr 20189:47 amRNSDirector/PDMR Shareholding
19th Apr 20189:44 amRNSDirector/PDMR Shareholding
11th Apr 20181:09 pmRNSDirector/PDMR Shareholding
11th Apr 20187:00 amRNSCapital Markets Event
3rd Apr 20182:19 pmRNSDirector/PDMR Shareholding
28th Mar 20182:39 pmRNSDirector/PDMR Shareholding
28th Mar 20182:38 pmRNSDirector/PDMR Shareholding
28th Mar 201812:19 pmRNSScheme of Arrangement becomes Effective
26th Mar 201812:09 pmRNSDirector/PDMR Shareholding - Replacement
22nd Mar 20182:41 pmRNSDirector/PDMR Shareholding
21st Mar 20183:16 pmRNSDirector/PDMR Shareholding
21st Mar 20182:56 pmRNSDirector/PDMR Shareholding
19th Mar 20185:45 pmRNSAnnual Financial Report
16th Mar 20181:47 pmRNSDirector/PDMR Shareholding
13th Mar 20182:18 pmRNSDirector/PDMR Shareholding
12th Mar 20182:03 pmRNSDirector/PDMR Shareholding
8th Mar 201811:20 amRNSDirector/PDMR Shareholding
8th Mar 201811:19 amRNSDirector/PDMR Shareholding
8th Mar 201811:18 amRNSDirector/PDMR Shareholding
8th Mar 201811:17 amRNSDirector/PDMR Shareholding
8th Mar 201811:17 amRNSDirector/PDMR Shareholding
8th Mar 201811:16 amRNSDirector/PDMR Shareholding
8th Mar 201811:15 amRNSDirector/PDMR Shareholding
8th Mar 201811:13 amRNSDirector/PDMR Shareholding
8th Mar 201811:10 amRNSDirector/PDMR Shareholding
8th Mar 201811:08 amRNSDirector/PDMR Shareholding
2nd Mar 20184:41 pmRNSTransaction in Own Shares
28th Feb 201810:19 amRNSReplacement:Results for the year ended 31 Dec 2017
27th Feb 20187:00 amRNSDirectorate Change
27th Feb 20187:00 amRNSResults for the year ended 31 December 2017
26th Feb 20183:34 pmRNSPublication of Scheme Document
26th Feb 20189:08 amRNSForm 8 (OPD) PLANT IMPACT PLC
16th Feb 20187:00 amRNSRecommended cash offer
15th Feb 20185:14 pmRNSDirector/PDMR Shareholding
13th Feb 20184:51 pmRNSDirector/PDMR Shareholding
11th Jan 20184:47 pmRNSDirector/PDMR Shareholding
11th Jan 20181:00 pmRNSTechnology acquisitions
12th Dec 20172:23 pmRNSDirector/PDMR Shareholding
13th Nov 20174:01 pmRNSDirector/PDMR Shareholding
31st Oct 20177:00 amRNSTrading Update for the Third Quarter 2017
17th Oct 20179:23 amRNSAppointment of KPMG LLP as External Auditor
11th Oct 20174:59 pmRNSDirector/PDMR Shareholding
4th Oct 20172:36 pmRNSDirector/PDMR Shareholding
14th Sep 20171:50 pmRNSDirector/PDMR Shareholding
12th Sep 20172:17 pmRNSDirector/PDMR Shareholding
11th Aug 20172:20 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSResults for the six months ended 30 June 2017
11th Jul 20174:22 pmRNSDirector/PDMR Shareholding
11th Jul 20173:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.